Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anupama E Gururaj

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Breast Cancer Research : BCR|January 12, 2005
p21-activated kinase signaling in breast cancerAnupama E Gururaj, Suresh K Rayala, Rakesh Kumar
Nature Immunology|October 4, 2024
AI and immunology as a new research paradigmAnupama E Gururaj, Richard H Scheuermann, Dawei Lin
Molecular and Cellular Biochemistry|March 7, 2003
Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferationAnupama E Gururaj, Madesh Belakavadi, Bharathi P Salimath
Nature Reviews. Cancer|May 26, 2006
p21-activated kinases in cancerRakesh Kumar, Anupama E Gururaj, Christopher J Barnes
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancerAnupama E Gururaj, Caroline Holm, Göran Landberg, et al.
Molecular Endocrinology (Baltimore, Md.)|May 17, 2007
Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1)Anupama E Gururaj, Shaohua Peng, Ratna K Vadlamudi, et al.
The Journal of Biological Chemistry|April 1, 2006
9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathwayRajesh R Singh, Anupama E Gururaj, Ratna K Vadlamudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerationsAnupama E Gururaj, Suresh K Rayala, Ratna K Vadlamudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
The clinical relevance of steroid hormone receptor corepressorsRakesh Kumar, Anupama E Gururaj, Ratna K Vadlamudi, et al.
Biochemical and Biophysical Research Communications|October 3, 2002
Molecular mechanisms of anti-angiogenic effect of curcuminAnupama E Gururaj, Madesh Belakavadi, Deepak A Venkatesh, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Breast Cancer Research : BCR|January 12, 2005
p21-activated kinase signaling in breast cancerAnupama E Gururaj, Suresh K Rayala, Rakesh Kumar
Nature Immunology|October 4, 2024
AI and immunology as a new research paradigmAnupama E Gururaj, Richard H Scheuermann, Dawei Lin
Molecular and Cellular Biochemistry|March 7, 2003
Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferationAnupama E Gururaj, Madesh Belakavadi, Bharathi P Salimath
Nature Reviews. Cancer|May 26, 2006
p21-activated kinases in cancerRakesh Kumar, Anupama E Gururaj, Christopher J Barnes
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancerAnupama E Gururaj, Caroline Holm, Göran Landberg, et al.
Molecular Endocrinology (Baltimore, Md.)|May 17, 2007
Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1)Anupama E Gururaj, Shaohua Peng, Ratna K Vadlamudi, et al.
The Journal of Biological Chemistry|April 1, 2006
9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathwayRajesh R Singh, Anupama E Gururaj, Ratna K Vadlamudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerationsAnupama E Gururaj, Suresh K Rayala, Ratna K Vadlamudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
The clinical relevance of steroid hormone receptor corepressorsRakesh Kumar, Anupama E Gururaj, Ratna K Vadlamudi, et al.
Biochemical and Biophysical Research Communications|October 3, 2002
Molecular mechanisms of anti-angiogenic effect of curcuminAnupama E Gururaj, Madesh Belakavadi, Deepak A Venkatesh, et al.
Pageof 3